Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Alder BiopharmaceuticalsLigand PharmaceuticalsTricidaAmneal PharmaceuticalsCorcept Therapeutics
SymbolNASDAQ:ALDRNASDAQ:LGNDNASDAQ:TCDANYSE:AMRXNASDAQ:CORT
Price Information
Current Price$18.88$97.23$36.72$4.91$13.34
52 Week RangeHoldBuyBuyHoldBuy
Analyst Ratings
Consensus RecommendationHoldBuyBuyHoldBuy
Consensus Price Target$18.44$164.80$51.50$6.30$17.33
% Upside from Price Target-2.34% downside69.50% upside40.25% upside28.31% upside29.94% upside
Trade Information
Market Cap$1.58 billionN/AN/A$1.49 billionN/A
Beta2.64N/AN/A1.76N/A
Average Volume5,117,415N/AN/A1,019,862N/A
Sales & Book Value
Annual Revenue$1.62 millionN/AN/A$1.86 billionN/A
Price / Sales977.10N/AN/A0.79N/A
CashflowN/AN/AN/A$1.41 per shareN/A
Price / CashN/AN/AN/A3.49N/A
Book Value$1.61 per shareN/AN/A$3.00 per shareN/A
Price / Book11.73N/AN/A1.64N/A
Profitability
Net Income$-296,430,000.00N/AN/A$-169,730,000.00N/A
EPS($4.87)$2.11($4.64)$0.95$0.60
Trailing P/E RatioN/A3.31N/AN/A18.53
Forward P/E RatioN/A35.10N/A10.6714.04
P/E GrowthN/AN/AN/A$0.75N/A
Net MarginsN/AN/AN/A-19.61%N/A
Return on Equity (ROE)-226.13%N/AN/A23.17%N/A
Return on Assets (ROA)-66.86%N/AN/A3.94%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.74%N/AN/A6.91%N/A
Current Ratio8.94%N/AN/A2.25%N/A
Quick Ratio8.94%N/AN/A1.50%N/A
Ownership Information
Institutional Ownership PercentageN/AN/A79.27%35.73%72.49%
Insider Ownership Percentage15.40%8.40%66.70%25.92%15.50%
Miscellaneous
Employees202116766,000166
Shares Outstanding83.84 millionN/AN/A299.10 millionN/A
Next Earnings DateN/A5/7/2020 (Estimated)3/26/2020 (Estimated)2/26/2020 (Confirmed)2/24/2020 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel